1. Home
  2. CRDF vs KGEI Comparison

CRDF vs KGEI Comparison

Compare CRDF & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$0.87

Market Cap

67.1M

Sector

Health Care

ML Signal

HOLD

KGEI

Kolibri Global Energy Inc.

SELL

Current Price

$4.86

Market Cap

191.0M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
CRDF
KGEI
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.1M
191.0M
IPO Year
2012
2009

Fundamental Metrics

Financial Performance
Metric
CRDF
KGEI
Price
$0.87
$4.86
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $6.28
N/A
AVG Volume (30 Days)
★ 346.5K
128.3K
Earning Date
11-12-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 27.37
N/A
EPS
N/A
★ N/A
Revenue
★ $365,993.00
N/A
Revenue This Year
N/A
$50.51
Revenue Next Year
$5.62
$13.89
P/E Ratio
★ N/A
$7.94
Revenue Growth
★ 49.61
N/A
52 Week Low
$0.71
$3.35
52 Week High
$3.31
$7.37

Technical Indicators

Market Signals
Indicator
CRDF
KGEI
Relative Strength Index (RSI) 50.36 29.65
Support Level $0.88 $4.74
Resistance Level $1.13 $5.34
Average True Range (ATR) 0.07 0.37
MACD 0.01 -0.16
Stochastic Oscillator 73.92 9.07

Price Performance

Historical Comparison
CRDF
KGEI

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1 inhibitor currently being evaluated in a Phase 2 trial for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC), addressing a large, underserved patient population with high unmet need. Onvansertib is also under investigation in other PLK1-driven cancers through ongoing investigator-initiated trials and has shown robust single agent clinical activity in hard-to-treat tumors. By targeting tumor vulnerabilities, to overcome treatment resistance and deliver improved clinical outcomes for patients.

About KGEI Kolibri Global Energy Inc.

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.

Share on Social Networks: